NASDAQ:JAGX Jaguar Animal Health (JAGX) Stock Price, News & Analysis $4.79 0.00 (0.00%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$4.84 +0.05 (+1.04%) As of 10/9/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsSEC Filings About Jaguar Animal Health Stock (NASDAQ:JAGX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Jaguar Animal Health alerts:Sign Up Key Stats Today's Range$4.47▼$5.3350-Day Range$2.67▼$34.4652-Week Range$2.35▼$1,260.00Volume1.07 million shsAverage Volume6.44 million shsMarket Capitalization$1.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Jaguar Animal Health, Inc. is a commercial-stage animal health company focused on developing and marketing products for gastrointestinal disorders in companion and production animals. Its research is centered on plant-based medicines, including products derived from the red-barked croton tree, Croton lechleri, traditionally used in South America. The company’s lead animal health product is Canalevia-CA1, a prescription drug containing crofelemer that received conditional approval from the U.S. Food and Drug Administration for the management of chemotherapy-induced diarrhea in dogs. Jaguar has also pursued additional applications for crofelemer and related gastrointestinal treatments in veterinary medicine, including products intended to address diarrhea and other digestive conditions. Jaguar’s broader business has included research and development activities through its Napo Pharmaceuticals subsidiary, which focuses on plant-derived medicines for gastrointestinal disorders in humans. The company works with commercial and research partners to support product development and distribution in the United States and selected international markets. Jaguar Animal Health was founded by Lisa Conte, who serves as its president and chief executive officer.AI Generated. May Contain Errors. Read More Jaguar Animal Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks11th Percentile Overall ScoreJAGX MarketRank™: Jaguar Animal Health scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingJaguar Animal Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageJaguar Animal Health has only been the subject of 1 research reports in the past 90 days.Read more about Jaguar Animal Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Jaguar Animal Health is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Jaguar Animal Health is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Jaguar Animal Health's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted24.46% of the float of Jaguar Animal Health has been sold short.Short Interest Ratio / Days to CoverJaguar Animal Health has a short interest ratio ("days to cover") of 0.01, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Jaguar Animal Health has recently decreased by 74.20%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldJaguar Animal Health does not currently pay a dividend.Dividend GrowthJaguar Animal Health does not have a long track record of dividend growth. News and Social Media3.3 / 5News Sentiment0.30 News SentimentJaguar Animal Health has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Jaguar Animal Health this week, compared to 1 article on an average week.Search Interest13 people have searched for JAGX on MarketBeat in the last 30 days. MarketBeat Follows3 people have added Jaguar Animal Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Jaguar Animal Health insiders have not sold or bought any company stock.Percentage Held by Insiders0.12% of the stock of Jaguar Animal Health is held by insiders.Percentage Held by Institutions12.04% of the stock of Jaguar Animal Health is held by institutions.Read more about Jaguar Animal Health's insider trading history. Receive JAGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jaguar Animal Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. JAGX Stock News HeadlinesJaguar Animal Health, Inc. (NASDAQ:JAGX) Shares Shorted: Short Interest Down 74.2% in SeptemberOctober 11 at 8:00 AM | americanbankingnews.comJaguar Animal Health (NASDAQ:JAGX) Share Price Breaks Below Fifty Day Moving Average - Time to Sell?October 10 at 3:21 AM | americanbankingnews.comUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider sources say Elon Musk is developing a breakthrough technology he describes as '10x bigger than the largest product in history.' Nvidia's CEO has called it 'the next biggest opportunity after AI,' with potential lifetime sales reaching $20 trillion. A launch date of July 22nd is on the radar for early investors positioning ahead of the announcement. | StocksToTrade (Ad)Wall Street Zen Upgrades Jaguar Animal Health (NASDAQ:JAGX) to SellOctober 10 at 1:25 AM | americanbankingnews.comJaguar Animal Health (NASDAQ:JAGX) versus Harrow (NASDAQ:HROW) Critical SurveyOctober 8, 2026 | americanbankingnews.comJaguar Health Targets Mid-2027 MVID NDA Filing as Crofelemer Intestinal Failure Program AdvancesOctober 6, 2026 | finance.yahoo.comAnalyzing ImmuCell (NASDAQ:ICCC) & Jaguar Animal Health (NASDAQ:JAGX)October 6, 2026 | americanbankingnews.comPainReform (NASDAQ:PRFX) vs. Jaguar Animal Health (NASDAQ:JAGX) Financial ContrastOctober 3, 2026 | americanbankingnews.comSee More Headlines JAGX Stock Analysis - Frequently Asked Questions How have JAGX shares performed this year? Jaguar Animal Health's stock was trading at $488.88 at the start of the year. Since then, JAGX stock has decreased by 99.0% and is now trading at $4.79. How were Jaguar Animal Health's earnings last quarter? Jaguar Animal Health, Inc. (NASDAQ:JAGX) released its earnings results on Wednesday, August, 19th. The biotechnology company reported ($15.70) earnings per share for the quarter, topping the consensus estimate of ($782.25) by $766.55. The biotechnology company had revenue of $1.23 million for the quarter, compared to the consensus estimate of $4.24 million. When did Jaguar Animal Health's stock split? Jaguar Animal Health shares reverse split on Thursday, May 23rd 2024.The 1-60 reverse split was announced on Thursday, May 23rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did Jaguar Animal Health IPO? Jaguar Animal Health (JAGX) raised $23 million in an IPO on Wednesday, May 13th 2015. The company issued 2,860,000 shares at a price of $7.00-$9.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers. How do I buy shares of Jaguar Animal Health? Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Jaguar Animal Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Jaguar Animal Health investors own include CrowdStrike (CRWD), NVIDIA (NVDA), Meta Platforms (META), Digital Turbine (APPS) and Advanced Micro Devices (AMD). Company Calendar Last Earnings8/19/2026Today10/11/2026Next Earnings (Estimated)11/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 7 days, JAGX's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:JAGX CIK1585608 Webwww.jaguar.health Phone(415) 371-8300FaxN/AEmployees47Year Founded2013Profitability EPS (Trailing Twelve Months)($3,731.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$53.43 million Net Margins-187.88% Pretax Margin-132.73% Return on EquityN/A Return on Assets-131.45% Debt Debt-to-Equity Ratio0.35 Current Ratio0.69 Quick Ratio0.40 Sales & Book Value Annual Sales$11.51 million Price / Sales0.14 Cash FlowN/A Price / Cash FlowN/A Book Value($1,590.93) per share Price / Book0.00Miscellaneous Outstanding Shares340,000Free Float345,000Market Cap$1.63 million OptionableNo Data Beta-0.11 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:JAGX) was last updated on 10/9/2026 by MarketBeat.com Staff. From Our PartnersUrgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20thMarc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a s...Chaikin Analytics | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredGold did this exact thing in 1975… [then exploded]In 1975 the Fed raised rates and gold fell 50 percent. Headlines called the gold bull market dead. Instead gol...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Animal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jaguar Animal Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
